(DGAP-Media / 26.03.2014 / 17:43) Heidelberg, March 2014. Precisis AG and Euromechanics Medical GmbH, two SME Medtech companies based in southern Germany announced the establishment of a joint venture with the focus on so-called "Multileaf-Collimators" for cancer treating radiotherapy. The new company's name is Precisis Euromechanics GmbH and it is headquartered in Heidelberg, one of Germany's top hubs for medical research. Under its main brand "P.E. Collimators" Precisis Euromechanics will start its worldwide promotion and marketing of the collimators (commonly known as "MLC") mainly used in modern cancer treatment. The unique portfolio consists of various MLCs for different applications, such as treatment with electrons or Cobalt-60 radiation. These devices, such as the eMLC or the CobraLeaf(R) have been developed and patented by P.E.'s mother founding companies. "With this broad portfolio plus years of experience and the Know-How of Precisis and Euromechanics, we expect substantial advantages over our competitors" says Stefan Ueltzhöffer, managing director of Precisis Euromechanics GmbH. The company considers itself as a direct contact for a worldwide market with more than 5,000 potential customers, mostly big Clinical Centers and radiotherapy practices in emerging nations and specialized High-tech clinical centers in the USA. Dr. Liedler, CEO of Precisis AG emphasizes the great synergies for both founding bodies, which will strengthen their international profile to a good extent. With this background in mind, the middle-term expansion of business to export to all BRICS countries and the set-up of a targeted sales team for the US market is a logical consequence. "After more than ten years of our collimators as OEM products being in worldwide use in hundreds of clinics, we appreciate the opportunity to fill the remaining gaps in the radiotherapy market with the newest developments in MLC technology", says Roman Harmansa, CEO of Euromechanics Medical GmbH. About Precisis Euromechanics GmbH Precisis Euromechanics GmbH was founded as a joint-venture of Precisis AG, Heidelberg and Euromechanics Medical GmbH, Schwarzenbruck with effective business in 2014. Under its main brand P.E. collimators develops and markets specialized accessory devices for cancer treatment with radiotherapy devices. Precisis Euromechanics' products have applications in the high-end clinical area as well as in cost-conscious clinics of emerging countries. Precisis Euromechanics is cooperating with the German cancer research center (DKFZ) in Heidelberg. About Euromechanics Medical GmbH Founded in 2000, Euromechanics Medical GmbH manufactures collimators, dosimetry devices and accessories as an OEM supplier for several major companies in the radiotherapy business field. The company is located in Schwarzenbruck near Nuremberg. The Euromechanics team of ten precision mechanics and mechanical engineers focuses on the development and manufacturing of high advanced precision mechanics. About Precisis AG Precisis AG is an innovative solution provider for stereotactic neurosurgery and radiation therapy. Alongside the enhancement of precision software systems that are already established in the market such as Praezis Plus(R) and Virtuos(R), the Heidelberg-based medical technology provider also works to advance the use of cranial brachytherapy, precision neurosurgery and special radiotherapy techniques. Its international team of ten employees is led by company president Dr. Angela Liedler, an experienced healthcare marketing and enterprise professional. =-- For more information please contact Precisis Euromechanics at: www.pe-collimators.com info@pe-collimators.com Precisis Euromechanics GmbH Hauptstr. 73 69117 Heidelberg Germany Tel: 06221-6559329 Fax: 06221-6559310 End of Media Release =-------------------------------------------------------------------- Issuer: Precisis Euromechanics GmbH Key word(s): Enterprise 26.03.2014 Dissemination of a Press Release, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de =-------------------------------------------------------------------- 259842 26.03.2014
(END) Dow Jones Newswires
March 26, 2014 12:43 ET (16:43 GMT)
© 2014 Dow Jones News
